Normalize the specification and commercial terms first, then assess documentation and continuity before selecting the source.
The source context
FDA’s letter to dietary supplement manufacturers discusses supplier qualification and raw-ingredient specifications. A purchase quote and a quality evaluation answer different questions. Source ↗
PCG perspective · The following is our proposed development framework, not a finding of the cited source.
Make the quotes comparable
Before comparing prices, check that suppliers are quoting the same identity, grade, specification, quantity, delivery terms, and documentation. A lower number may reflect a different scope. Create a short comparison sheet with explicit assumptions and unresolved questions. This saves time when commercial and technical teams review the options together and prevents an apparent saving from becoming a later redesign.
Follow the documentation trail
Ask what documentation accompanies each lot, who generates it, and how the information connects to the material being supplied. Clarify the process for deviations, changes, and disputes. The goal is not to collect the largest folder of certificates; it is to understand how the team will make a release decision and what happens when information is incomplete or inconsistent.
Understand supply continuity
Review lead times, minimum orders, production location, capacity constraints, and the availability of alternatives. An alternate source is not automatically a drop-in replacement. Identify what would need to be checked before a substitution could be used. Put those steps into the continuity plan while the primary supply relationship is working, rather than inventing them during a shortage.
Choose on delivered value
Compare the total effect on the product: material cost, testing, freight, working capital, qualification effort, and the risk of delay. A slightly higher purchase price can still be attractive if it reduces a meaningful operational burden, but that conclusion should be documented rather than assumed. Keep the sourcing rationale available for future teams so the decision survives a personnel change.
Source & scope
FDA: Letter to Manufacturers of Dietary Supplements ↗Supplier qualification guidance; checked September 21, 2026. Sources checked September 21, 2026. Product-specific scientific and regulatory conclusions require appropriate specialist review.
How we prepare and update insightsRelated PCG service
Ingredient sourcing & raw material development ↗Turn the question into a development brief.
Explore formulation, sourcing, research, or portfolio decisions with Product Concept Group.
Discuss this opportunity ↗